| Name | Title | Contact Details |
|---|
The CHC Alliance is a company that specializes in FQHC Revenue Cycle Management and Billing & Credentialing. They help community health centers reach their maximum potential by providing expertise in the field and ensuring that FQHCs get paid every dol...
Cityblock was founded in 2017 as the first tech-driven provider for communities with complex needs. We deliver better care to where it`s needed most, investing upstream in highly personalized, prevention-oriented health and social care to ultimately drive down costs and improve outcomes. Our tech enables scale by bringing together practical information, coordination, and communication for our members and our care teams. We are adamant about building a radically better member experience for people living in lower-income neighborhoods that have never been prioritized.
LeMaitre Vascular, Inc. (LeMaitre Vascular) is a provider of medical devices and implants for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices.
WAVE Life Sciences is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering exceptional treatment options for patients. Given the unique versatility of its chemistry platform, WAVE`s pipeline will span multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi.
SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT™ Optical Biopsy System uses light to optically scan tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use. The Company's LUMA imaging technology has received FDA approval for an optical non-invasive system that is proven to more effectively detect cervical cancer precursors than conventional methods available in the market today.